Convano Reports Significant Turnaround in Operating Profit and Record Revenue for Q3 FY 2026

Convano Experiences Remarkable Growth in Q3 FY 2026

Convano Inc., headquartered in Shibuya, Tokyo, and led by CEO Akira Uekawa (stock code: 6574), has released its financial results for the third quarter of the fiscal year ending March 2026, reporting impressive figures that underline the strength of its business portfolio.

Financial Highlights

In the cumulative third quarter of FY 2026 (from April 1, 2025, to December 31, 2025), Convano's total revenue reached a staggering 9.195 billion yen (approximately $92 million). This represents a remarkable year-on-year revenue growth of 292.8% compared to the same quarter last year, where revenues were just 2.341 billion yen.

Operating and Net Profit

More notably, Convano experienced a significant reversal in operating profit, transitioning from a loss of 75 million yen to an operating profit of 4.414 billion yen. The net profit also turned positive, achieving 2.958 billion yen from a previous loss of 86 million yen. These figures reflect Convano's solid recovery and strategic advancements in its core business areas.

Strong Growth in Consulting and Healthcare

The growth was primarily driven by the consulting and healthcare segments of the business. Convano's subsidiary, DataStrategy, leverages group synergies to enhance its business, especially in the AI sector, achieving sales growth approximately 23 times higher than the previous year.

Moreover, Healthcare subsidiary, Sinks Healthcare, has seen a significant uptick in transactions, particularly in high-value medical hyaluronic acid products. Collaborating with LG Chem Ltd., the company is progressing towards domestic regulatory approvals, reinforcing its position in the market.

Forecast Adjustments

Convano has shown consistent progress toward its full-year performance goals, revising its forecasts based on the rapid growth of its consolidated subsidiaries. According to the initial plans announced on November 21, 2025, the company has experienced promising developments.

Projected total revenues are expected to soar from 3.241 billion yen in FY 2025 to 14.950 billion yen in FY 2026, marking an impressive increase of 361.3%. Operating profit is anticipated to grow from 135 million yen to 5.990 billion yen, representing an extraordinary rise of 4,337%.

Future Outlook

Looking forward, Convano is committed to maintaining its trajectory of dynamic growth through innovative approaches. The company continues to enhance its network in the healthcare sector, aiming to become a leading figure in the industry by utilizing its strengths in digital marketing and AI system development.

As a fast-growing nail service chain under the FASTNAIL brand, Convano is well-equipped to transition into the WEB3 infrastructure sphere, cementing its status as a next-generation platform developer originating from Japan.

For more detailed information, please visit the following links:

In summary, Convano's strategic initiatives in consulting and healthcare have led to unprecedented success in the third quarter of FY 2026, and their proactive measures suggest a bright future ahead as they expand their influence in Japan and beyond.